LISINOPRIL/HYDROCHLOROTHIAZIDE ZENTIVA 20 mg/12,5 mg, comprimé sécable — plaquette(s) PVC PVDC aluminium de 90 comprimé(s)

Conditionnement de médicament · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400937874892
  • CIP7 3787489
  • CIS 67874804

Ce que publie la source

Titulaire
ZENTIVA FRANCE
Substances actives
HYDROCHLOROTHIAZIDE, LISINOPRIL ANHYDRE, LISINOPRIL DIHYDRATÉ
Forme
comprimé sécable
Conditionnement
plaquette(s) PVC PVDC aluminium de 90 comprimé(s)
Voies d’administration
orale
Statut administratif
authorised
Régime de délivrance
liste I
Statut de commercialisation
Déclaration de commercialisation
Date d’autorisation
2006-02-08
Prescription
Sur ordonnance ou à délivrance restreinte

Noms permettant de trouver cette fiche

Données complètes de la source
fr:ansm:packages:3400937874892
{
  "cis": "67874804",
  "cip7": "3787489",
  "form": "comprimé sécable",
  "name": "LISINOPRIL/HYDROCHLOROTHIAZIDE ZENTIVA 20 mg/12,5 mg, comprimé sécable — plaquette(s) PVC PVDC aluminium de 90 comprimé(s)",
  "cip13": "3400937874892",
  "holder": "ZENTIVA FRANCE",
  "routes": [
    "orale"
  ],
  "holders": [
    "ZENTIVA FRANCE"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "13.61",
  "authorisedOn": "2006-02-08",
  "compositions": [
    {
      "name": "HYDROCHLOROTHIAZIDE",
      "nature": "SA",
      "strength": "12,5 mg",
      "linkageNumber": "2",
      "substanceCode": "02064",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "LISINOPRIL ANHYDRE",
      "nature": "FT",
      "strength": "20 mg",
      "linkageNumber": "1",
      "substanceCode": "15304",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "LISINOPRIL DIHYDRATÉ",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "60255",
      "dosageReference": null,
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "2.76",
  "medicinePrice": "10.85",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "LISINOPRIL/HYDROCHLOROTHIAZIDE ZENTIVA 20 mg/12,5 mg, comprimé sécable",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) PVC PVDC aluminium de 90 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65 %"
  ],
  "marketingDeclaredOn": "2023-06-30",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "HYDROCHLOROTHIAZIDE",
    "LISINOPRIL ANHYDRE",
    "LISINOPRIL DIHYDRATÉ"
  ],
  "authorisationProcedure": "Procédure nationale",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Lisez cette fiche depuis votre propre logiciel

La même fiche, avec tous ses champs et sa provenance, est à portée d’une requête. Une clé API est gratuite et fonctionne immédiatement.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400937874892"